Loading…
S. 1406119th CongressIn committeeLatest action Apr 10, 2025Decoded by AI · checked against the record
The plain-language version leads. The official text is always the reference.
The SOAR Act of 2025 would remove home oxygen from Medicare's competitive bidding program starting in 2026.
35-second read · 4 questions answered below
This bill removes home oxygen equipment from Medicare's competitive bidding program starting in 2026 and replaces it with a new payment formula, including higher rates for liquid oxygen and extra payments for high oxygen flow needs. It also defines required supplier services, allows direct Medicare payment for respiratory therapists, creates a standardized doctor form to justify oxygen need, and establishes a formal list of patient rights.
Medicare beneficiaries who use home oxygen therapy, durable medical equipment suppliers, and respiratory therapists.
The changes could alter how much suppliers are paid and what services and protections patients are guaranteed, affecting access to and quality of home oxygen therapy under Medicare.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on Finance.